Autolus Therapeutics Ltd | AUTL - Cash And Equivalent

Stock Price
1.71
Daily Change
-0.06 -3.13%
Monthly
22.66%
Yearly
-6.32%
Q1 Forecast
1.64

Autolus Therapeutics Ltd reported $86.12M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
AstraZeneca USD 8.14B 1.08B Sep/2025
Autolus Therapeutics Ltd USD 86.12M 37.7M Sep/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Novartis USD 9.56B 2.9B Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Silence Therapeutics USD 57.19M 4.77M Jun/2025